CPVT1

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Cardurion Pharmaceuticals
1 program
1
CRD-4730Phase 21 trial
Active Trials
NCT06005428TerminatedEst. May 2025

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
Cardurion PharmaceuticalsCRD-4730

Clinical Trials (1)

Effectiveness of CRD-4730 in Participants With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

Start: Nov 2023Est. completion: May 2025
Phase 2Terminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space